May 29, 2014
Area(s) of Interest: Advocacy Practice Management
Physicians can now begin the registration process to review and potentially dispute their data reported by manufacturers of drugs and medical devices under the Physician Payments Sunshine Act. According to the Centers for Medicare & Medicaid Services (CMS), physicians will be able to begin reviewing the disclosure data sometime in July. Physicians will then have 45 days to review and dispute their data (plus an additional 15 days to resolve disputes).
Under the Sunshine Act, drug and medical device manufacturers are required to report their financial interactions with licensed physicians – including consulting fees, travel reimbursements, research grants and other gifts. Any payments, ownership interests and other “transfers of value” will be reported to CMS for publication in an online database to be launched this fall.
The two-step registration process first requires physicians to register at the CMS Enterprise Portal, a step many physicians may have already completed as the gateway enables access to a number of other CMS programs. Step two will be registration in CMS’ Open Payments system, which is set to begin in early July. More information on how to register will be available on the CMS website.
For more information, see the American Medical Association's online “Physician Sunshine Act Tool Kit,” which provides a variety of resources to help physicians navigate the Sunshine Act changes, including a free webinar, a list of important dates, answers to frequently asked questions, information about how to challenge incorrect reports and ways to be more transparent with patients about the physician's interactions with the pharmaceutical and medical device industries.